In recent year’s many studies were published related to a number of cardiovascular pathologies and, also, to Space Weather effects on human health-a part of Clinical Cosmobiology. These studies are related to close associated Solar (SA) and Geomagnetic Activity (GMA) and their Antagonist Cosmic Ray (CRA) (Neutron) Activity. At days of extreme high (Stormy-IV0)) GMA such risk factors like arterial blood pressure, blood coagulation parameters, markers of inflammation (CRP), some immune system signs are rising. SA is inverse correlated to CRA r=-0.85, p=0.0001; GMA/CRA= -0.66,0.0001; and SA/GMA are related by r=0.55, p Aim The aim of this study is to discuss, if the prescribed to patients pharmacotherapy must consider the mentioned links and adjust the drug doses to the EPA and adapt them to changing, especially extreme Space Whether events. Methods The basis for this study were many decades of clinical comparisons of medical events and their outcomes with daily, monthly, yearly Space Weather activity, concomitant laboratory test results; comparison of data related to different levels of Space Whether Activity and discussion of adopted pharmacotherapy, if its possible. Conclusion Presented data show that at days of extreme Space Weather activity many risk factors of Cardiovascular Disease are changing their levels. The question is, if fluctuating, in accord to Space Weather prediction, drug dose can be effective At days of high CRA (Neutron) activity the use of artificial magnetic fields by high risk patients is a possibility worth to check. At the days higher CRA (Neutron) activity more active measures against air pollution are recommended. Keywords: Arrhythmia; Acute;Cosmic Ray; Coagulation; Cardiac; Events;Geomagnetic; Inflammation; Neutron Activity; Pharmacotherapy.
Read full abstract